Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 290-824-9 | CAS number: 90268-24-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Testing for sensitizing properties of PY176 was performed in female guinea pigs according to the method of Magnusson & Kliggman. Intradermal induction was perfored using 1% test item in hydroxyethyl-cellulose (1% in water). Dermal induction and challenge treatment were carried out with 25% test item in hydroxyethyl-cellulose (1% in water) (corresponding to 14.7% P.Y. 176 in hydroxyethyl cellulose - 1% in water ). Based on the results of this study the test item showed no evidence of sensitizing properties. Therefore, the test item has not to be classified as skin sensitiser according to Regulation (EC) No 1272/2008.
In the study the analogue substance PY13 suspended in propylene glycol was assessed for its possible contact allergenic potential.
For this purpose a local lymph node assay was performed using test item concentrations of 2.5, 5 and 10% (w/v).
The animals (4 female mice/dose grouop) did not show any clinical signs during the course of the study and no cases of mortality were observed. In this study Stimulation Indices (S.I.) of 1.71, 1.32 and 2.26 were determined with the test item at concentrations of 2.5, 5 and 10% (w/v) in propylene glycol, respectively. The results obtained with the positive control confirmed the validity of the test.
The test item was not a skin sensitiser in this assay.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in chemico
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study are available
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- an in vitro skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study are available
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 09 AUG 2006 to 15 AUG 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: guideline study (OECD TG 429)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GLP according to Chemikaliengesetz and Directive 88/320/EEC
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- strain: CBA/CaOlaHsd
- Source: Harlan Netherlands
- Age at study initiation: 7-8 weeks (beginning of acclimatization)
- Weight at study initiation: mean: 19.2 g (17.1-20.8)
- Housing: individually, Makrolon Type I cages
- Diet: pelleted standard diet (Harlan Winkelmann, Borchen), ad libitum
- Water: tap water, ad libitum
- Acclimatization: yes (acclimatization period not given)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/-3
- Humidity (%): 30-85%
- Photoperiod (hrs dark / hrs light): 12 hrs/12 hrs
- Vehicle:
- propylene glycol
- Concentration:
- 0%, 2.5%, 5%, 10% (w/v)
- No. of animals per dose:
- 4 females per dose group
2 females in the pre-test - Details on study design:
- RANGE FINDING TESTS:
- non GLP
- Compound solubility: 10% (w/v) suspension in propylene glycol was the highest technically applicable concentration; higher concentrations could also not be achieved with other vehicles
- Irritation: no irritation effects were observed at these concentrations after a single application
- Lymph node proliferation response: no data
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response:
1: exposure to at least one concentration of the test item resulted in an incorporation of 3H-methyl thymidine at least 3-fold or greater than that recorded in control mice as indicated by the stimulation index
2: data are compatible with a conventional dose response, although allowance must be made for either local toxicity or immunological suppression
TREATMENT PREPARATION AND ADMINISTRATION:
- individual preparation of weight volume dilutions using a magnetic stirrer as homogenizer
- test item preparations were made freshly before each dosing occasion
- 25 µl were spread over the entire dorsal surface of each ear lobe once daily for three consecutive days - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- - calculation of mean values and standard deviations for body weight
- Positive control results:
- Stimulation indices of 2.30, 4.31 and 11.21 were determined with the positive control substance at concentrations of 5%, 10% and 25% (w/v), respectively, in acetone:olive oil (4+1). An EC3 value of 6.7% (w/v) was calculated.
- Key result
- Parameter:
- SI
- Value:
- 2.26
- Test group / Remarks:
- 10%
- Key result
- Parameter:
- SI
- Value:
- 17.1
- Test group / Remarks:
- 2,5%
- Remarks on result:
- other: Stimulation indices were all below 3. The following SI were calculated: 2.5% test item: 1.71 5% test item: 1.32 10% test item: 2.26
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- There was a dose dependent increase in the dpm, which were measured for the pooled lymph nodes of each treatment group (8 lymph nodes per dose group): Background: 17.56 or 20.36 dpm Control group: 3102.24 dpm 2.5% test item: 5291.91 dpm 5% test item: 4100.26 dpm 10% test item: 6990.34 dpm
- Key result
- Parameter:
- SI
- Value:
- 1.32
- Test group / Remarks:
- 5%
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- The test substance was not sensitising in this LLNA in concentrations up to 10% (w/v) in propylene glycol, the highest technically achievable concentration.
- Executive summary:
In the study the test item suspended in propylene glycol was assessed for its possible contact allergenic potential.
For this purpose a local lymph node assay was performed using test item concentrations of 2.5, 5 and 10% (w/v).
The animals (4 female mice/dose grouop) did not show any clinical signs during the course of the study and no cases of mortality were observed. In this study Stimulation Indices (S.I.) of 1.71, 1.32 and 2.26 were determined with the test item at concentrations of 2.5, 5 and 10% (w/v) in propylene glycol, respectively. The results obtained with the positive control confirmed the validity of the test.
The test item was not a skin sensitiser in this assay. Therefore, the test item has not to be classified as skin sensitiser according to Regulation (EC) No 1272/2008.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 28 APR 1998 to 29 MAY 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: guideline study (OECD TG 406)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- At the time of study performance the applied test method was recommended by OECD as a standard method. OECD TG 429 was not yet available.
- Species:
- guinea pig
- Strain:
- other: Pirbright HsdPoc:DH
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Weight at study initiation: mean: 369 g
- Housing: in groups of 5 animals, Macrolon cages Type 4
- Diet: ssniff Ms-H (V2233), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 +/- 3
- Humidity (%): 50 +/- 20
- Photoperiod (hrs dark / hrs light): 12 hrs/12hrs
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: control group: sesame oil DAB 10; treatment group: hydroxyethyl-cellulose (1 % in water)
- Concentration / amount:
- 1%: intradermal induction
25%: dermal induction and challenge - Route:
- epicutaneous, occlusive
- Vehicle:
- other: control group: sesame oil DAB 10; treatment group: hydroxyethyl-cellulose (1 % in water)
- Concentration / amount:
- 1%: intradermal induction
25%: dermal induction and challenge - No. of animals per dose:
- 10 animals per treatment group
5 animals in control group
2 animals for determination of the tolerance of the intradermal injections
3 animals for determination of the primary non-irritant concentration - Details on study design:
- RANGE FINDING TESTS:
- Determination of primary non-irritation concentration in a dermal occlusive test: application of 0.5 ml of a 1%, 5% or 25% test item preparation in hydroxyethyl-cellulose (1% in water) to the flanks, occlusive exposure for 24 hours; reading 24 hours after patch removal.
-Determination of the tolerance of the intradermal injections: application of 0.1 ml of 0.2%, 1.0% or 5.0% preparation in hydroxyethyl-cellulose (1% in water) at the dorsal area; examination for local tolerance: 24, 48, 72 and 96 hours after administration.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3 pairs of indtradermal injections and one dermal exposure
- Site: dorsal area
- Frequency of applications: day 1: intradermal induction; day 8: start of dermal induction (lasting for 48 hours, occlusive)
- Concentrations:
Treatment group:
intradermal: 0.1 ml of 50% FCA or 1% preparation in hydroxyethyl-cellulose (1% in water) or 1% preparation in 50% FCA; dermal: 0.5 ml of 25% preparation in hydroxyethyl-cellulose (1% in water)
Control group:
intradermal: 0.1 ml of 50% FCA or sesam oil or sesam oil:50% FCA (1+1); dermal: 0.5 ml of hydroxyethyl-cellulose (1% in water)
B. CHALLENGE EXPOSURE
- No. of exposures: one
- Day of challenge: day 22 of the study
- Exposure period: 24 hours, occlusive
- Site: left flank
- Concentrations: 25% preparation of test item in hydroxyethyl-cellulose (1% in water)
- Evaluation (hr after challenge): 24 and 48 hours after removal of the patch (day 24 and 25 of the study)
- Challenge controls:
- - none
- Positive control substance(s):
- yes
- Remarks:
- Benzocain
- Positive control results:
- Intradermal induction: 1 % Benzocain in sesame oil
first challenge (day 22) with 25% Benzocain in sesame oil: 20% (2 of10) of the animals showed a positive reaction at the first reading after 24 hrs
second challenge (day 29) with 25% Benzocain in sesame oil: 50% (5 of 10) of the animals showed a positive reaction at the first reading after 24 hrs - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25% in hydroxyethyl-cellulose (1% in water)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No clinical signs of toxicity, no impairment of body weight gains.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25% in hydroxyethyl-cellulose (1% in water). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No clinical signs of toxicity, no impairment of body weight gains..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25% in hydroxyethyl-cellulose (1% in water)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No clinical signs of toxicity, no impairment of body weight gains.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25% in hydroxyethyl-cellulose (1% in water). No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No clinical signs of toxicity, no impairment of body weight gains..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25% in hydroxethyl-cellulose (1% in water)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No clinical signs of toxicity, no impairment of body weight gains.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25% in hydroxethyl-cellulose (1% in water). No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No clinical signs of toxicity, no impairment of body weight gains..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25% in hydroxyethyl-cellulose (1% in water)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No clinical signs of toxicity, no impairment of body weight gains.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25% in hydroxyethyl-cellulose (1% in water). No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No clinical signs of toxicity, no impairment of body weight gains..
- Interpretation of results:
- not sensitising
- Conclusions:
- The test substance was not sensitising in concentrations up to 25% in hydroxyethyl cellulose (1% in water) (corresponding to 14.7% P.Y. 176 in hydroxyethyl cellulose - 1% in water ) in this guinea pig maximization test. This test was considered sufficient to fulfil the information requirements.
- Executive summary:
Testing for sensitizing properties of the test item was performed in female guinea pigs according to the method of Magnusson & Kliggman. Intradermal induction was perfored using 1% test item in hydroxyethyl-cellulose (1% in water). Dermal induction and challenge treatment were carried out with 25% test item in hydroxyethyl-cellulose (1% in water) (corresponding to 14.7% P.Y. 176 in hydroxyethyl cellulose - 1% in water ). Based on the results of this study the test item showed no evidence of sensitizing properties. Therefore, the test item has not to be classified as skin sensitiser according to Regulation (EC) No 1272/2008.
Referenceopen allclose all
The animals did not show any clinical signs during the course of the study and no cases of mortality were observed. The body weight of the animals was within the normal range. Calculation of the EC3 value was not performed, because no test concentration produced a SI of 3 or higher.
- Intradermal Induction: Intradermal injections with FCA (with and without test substance) caused severe erythema and oedemas as well as indurations and encrustations. Administration sites treated with test substance showed slight erythema and oedema. Sesame oil did not induce irritations.
- Dermal Induction: After removal of the patches severe erythema and oedema, indurated and encrusted skin as well as necrosis were observed at the sites previously treated with FCA. Administration sites treated with test substance or sesame oil showed no signs of irritation.
- Challenge: In all cases the treated skin areas were discoloured slight yellow. No signs of irritation were observed in the control and treatment group 24 and 48 hours after removal of the occlusive bandage.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
No classification
The test item did no cause sensitising effects in a maximisation test in Guinea pigs. The close analogue PY13 did not reveal sensitising properties in an LLNA in mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.